Pharmacokinetics of Penicillin G in Very-Low-Birth-Weight Neonates
Authors:
- 1 June 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (6) , 1995-2000
Abstract
Data on the pharmacokinetics (PKs) of penicillin G (PEN) in neonates date back to the 1970s and do not include data for very-low-birth-weight (VLBW) neonates. The aim of this study was to describe the steady-state PKs and to establish an optimal regimen for the dosing of PEN in neonates with gestational ages of less than 28 weeks and birth weights of less than 1,200 g. Two PEN dosing regimens were studied: 50,000 IU (30 mg)/kg of body weight every 12 h (q12h) (group 1; n = 9) and 25,000 IU (15 mg)/kg q12h (group 2; n = 9). Samples for PK analysis were drawn before the injection of PEN and at 2 and 30 min and 1.5, 4, 8, and 12 h after intravenous injection of the third to eighth PEN doses. The PEN concentration was measured by a high-performance liquid chromatography with UV detection technique. The median peak and trough concentrations of PEN were 147 μg/ml (lower and upper quartiles, 109 and 157 μg/ml, respectively) and 7 μg/ml (lower and upper quartiles, 5 and 13 μg/ml, respectively) after administration of the dose of 50,000 IU and 59 μg/ml (lower and upper quartiles, 53 and 78 μg/ml, respectively) and 3 μg/ml (lower and upper quartiles, 3 and 4 μg/ml, respectively) after administration of the dose of 25,000 IU. The PEN half-life (median and lower and upper quartiles for group 1, 3.9 h and 3.3 and 7.0 h, respectively; median and lower and upper quartiles for group 2, 4.6 h and 3.8 and 5.6 h, respectively) was longer in VLBW neonates than in adults and term infants. PEN renal clearance correlated with creatinine clearance ( R 2 = 0.309596; P = 0.038). Only a median of 34% (lower and upper quartiles, 28 and 37%, respectively) of the administered dose was excreted in urine within the following 12 h. We conclude that in VLBW infants a PEN dose of 25,000 IU (15 mg)/kg q12h is safe and sufficient to achieve serum concentrations above the MIC 90 for group B streptococci for the entire dosing interval.Keywords
This publication has 31 references indexed in Scilit:
- SEROTYPES, GENOTYPES, AND ANTIBIOTIC SUSCEPTIBILITY PROFILES OF GROUP B STREPTOCOCCI CAUSING NEONATAL SEPSIS AND MENINGITIS BEFORE AND AFTER INTRODUCTION OF ANTIBIOTIC PROPHYLAXISThe Pediatric Infectious Disease Journal, 2006
- Population Pharmacokinetics of Cefepime in the NeonateAntimicrobial Agents and Chemotherapy, 2005
- Effects of Intrapartum Penicillin Prophylaxis on Intestinal Bacterial Colonization in InfantsJournal of Clinical Microbiology, 2004
- Ampicillin and Penicillin Concentration in Serum and Pleural Fluid of Hospitalized Children With Community-Acquired PneumoniaThe Pediatric Infectious Disease Journal, 2004
- Streptococcus agalactiae in a Large Portuguese Teaching Hospital: Antimicrobial Susceptibility, Serotype Distribution, and Clonal Analysis of Macrolide-Resistant IsolatesMicrobial Drug Resistance, 2004
- Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in preterm infants with a birth weight below 1500 gEuropean Journal of Pediatrics, 1996
- Clinical Pharmacokinetics of Antibacterial Drugs in NeonatesClinical Pharmacokinetics, 1990
- A Pharmacologic Evaluation of Penicillin in Children with Purulent MeningitisNew England Journal of Medicine, 1977
- Pharmacologic studies in neonates given large dosages of ampicillinThe Journal of Pediatrics, 1974
- Clinical pharmacology of penicillin in newborn infantsThe Journal of Pediatrics, 1973